A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias von Cortes, J.E, Kim, D.-W, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, F.E, Apperley, J.F, Khoury, H.J, Talpaz, M, DiPersio, J, DeAngelo, D.J, Abruzzese, E, Rea, D, Baccarani, M, Müller, M.C, Gambacorti-Passerini, C, Wong, S, Lustgarten, S, Rivera, V.M, Clackson, T, Turner, C.D, Haluska, F.G, Guilhot, F, Deininger, M.W, Hochhaus, A, Hughes, T, Goldman, J.M, Shah, N.P, Kantarjian, H

Volltext

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) von Hanfstein, B, Müller, M C, Hehlmann, R, Erben, P, Lauseker, M, Fabarius, A, Schnittger, S, Haferlach, C, Göhring, G, Proetel, U, Kolb, H-J, Krause, S W, Hofmann, W-K, Schubert, J, Einsele, H, Dengler, J, Hänel, M, Falge, C, Kanz, L, Neubauer, A, Kneba, M, Stegelmann, F, Pfreundschuh, M, Waller, C F, Branford, S, Hughes, T P, Spiekermann, K, Baerlocher, G M, Pfirrmann, M, Hasford, J, Saußele, S, Hochhaus, A

Volltext

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia von Hochhaus, A, O'Brien, S G, Guilhot, F, Druker, B J, Branford, S, Foroni, L, Goldman, J M, Müller, M C, Radich, J P, Rudoltz, M, Mone, M, Gathmann, I, Hughes, T P, Larson, R A

Volltext

Standardized definitions of molecular response in chronic myeloid leukemia von Cross, N C P, White, H E, Müller, M C, Saglio, G, Hochhaus, A

Volltext

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV von Kalmanti, L, Saussele, S, Lauseker, M, Müller, M C, Dietz, C T, Heinrich, L, Hanfstein, B, Proetel, U, Fabarius, A, Krause, S W, Rinaldetti, S, Dengler, J, Falge, C, Oppliger-Leibundgut, E, Burchert, A, Neubauer, A, Kanz, L, Stegelmann, F, Pfreundschuh, M, Spiekermann, K, Scheid, C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R

Volltext

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML von Schütz, C, Inselmann, S, Sausslele, S, Dietz, C T, Müller, M C, Eigendorff, E, Brendel, C A, Metzelder, S K, Brümmendorf, T H, Waller, C, Dengler, J, Goebeler, M E, Herbst, R, Freunek, G, Hanzel, S, Illmer, T, Wang, Y, Lange, T, Finkernagel, F, Hehlmann, R, Huber, M, Neubauer, A, Hochhaus, A, Guilhot, J, Xavier Mahon, F, Pfirrmann, M, Burchert, A

Volltext

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia von Cross, N C P, White, H E, Colomer, D, Ehrencrona, H, Foroni, L, Gottardi, E, Lange, T, Lion, T, Machova Polakova, K, Dulucq, S, Martinelli, G, Oppliger Leibundgut, E, Pallisgaard, N, Barbany, G, Sacha, T, Talmaci, R, Izzo, B, Saglio, G, Pane, F, Müller, M C, Hochhaus, A

Volltext

Kink far below the Fermi level reveals new electron-magnon scattering channel in Fe von Młyńczak, E., Müller, M. C. T. D., Gospodarič, P., Heider, T., Aguilera, I., Bihlmayer, G., Gehlmann, M., Jugovac, M., Zamborlini, G., Tusche, C., Suga, S., Feyer, V., Plucinski, L., Friedrich, C., Blügel, S., Schneider, C. M.

Volltext

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy von HOCHHAUS, A, KREIL, S, GSCHAIDMEIER, H, DRUKER, B. J, HEHLMANN, R, CORBIN, A. S, ROSEE, P. La, MÜLLER, M. C, LAHAYE, T, HANFSTEIN, B, SCHOCH, C, CROSS, N. C. P, BERGER, U

Volltext

A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases von Grossmann, V, Kohlmann, A, Zenger, M, Schindela, S, Eder, C, Weissmann, S, Schnittger, S, Kern, W, Müller, M C, Hochhaus, A, Haferlach, T, Haferlach, C

Volltext

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV von Miranda, M B, Lauseker, M, Kraus, M-P, Proetel, U, Hanfstein, B, Fabarius, A, Baerlocher, G M, Heim, D, Hossfeld, D K, Kolb, H-J, Krause, S W, Nerl, C, Brümmendorf, T H, Verbeek, W, Fauser, A A, Prümmer, O, Neben, K, Hess, U, Mahlberg, R, Plöger, C, Flasshove, M, Rendenbach, B, Hofmann, W-K, Müller, M C, Pfirrmann, M, Hochhaus, A, Hasford, J, Hehlmann, R, Saußele, S

Volltext

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma von METZGEROTH, G, WALZ, C, MÜLLER, M. C, BENEKE, H, MÜLLER, L, DEL VALLE, F, AULITZKY, W. E, WITTKOWSKY, G, SCHMITZ, N, SCHULTE, C, MULLER-HERMELINK, K, HODGES, E, SCORE, J, WHITTAKER, S. J, DIECKER, F, DÖHNER, H, SCHULD, P, HEHLMANN, R, HOCHHAUS, A, CROSS, N. C. P, REITER, A, SIEBERT, R, SCHNITTGER, S, HAFERLACH, C, POPP, H, HAFERLACH, T, ERBEN, P, MIX, J

Volltext

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale von Cross, N C P, White, H E, Ernst, T, Welden, L, Dietz, C, Saglio, G, Mahon, F-X, Wong, C C, Zheng, D, Wong, S, Wang, S-S, Akiki, S, Albano, F, Andrikovics, H, Anwar, J, Balatzenko, G, Bendit, I, Beveridge, J, Boeckx, N, Cerveira, N, Cheng, S-M, Colomer, D, Czurda, S, Daraio, F, Dulucq, S, Eggen, L, El Housni, H, Gerrard, G, Gniot, M, Izzo, B, Jacquin, D, Janssen, J J W M, Jeromin, S, Jurcek, T, Kim, D-W, Machova-Polakova, K, Martinez-Lopez, J, McBean, M, Mesanovic, S, Mitterbauer-Hohendanner, G, Mobtaker, H, Mozziconacci, M-J, Pajič, T, Pallisgaard, N, Panagiotidis, P, Press, R D, Qin, Y-Z, Radich, J, Sacha, T, Touloumenidou, T, Waits, P, Wilkinson, E, Zadro, R, Müller, M C, Hochhaus, A, Branford, S

Volltext

Program on high value cost-conscious education in intensive care: Educational program on prediction of outcome and cost awareness on Intensive Care admission von van Wagenberg, L, Beurskens, C J P, Stegeman, I, Müller, M C A

Volltext

Melatonin improves development, mitochondrial function and promotes the meiotic resumption of sheep oocytes from in vitro grown secondary follicles von Barros, V.R.P., Monte, A.P.O., Santos, J.M.S., Lins, T.L.B.G., Cavalcante, A.Y.P., Gouveia, B.B., Müller, M.C., Oliveira, J.L., Donfack, N.J., Araújo, V.R., Matos, M.H.T.

Volltext

Fatal progressive cerebral ischemia in CML under third-line treatment with ponatinib von Mayer, K, Gielen, G H, Willinek, W, Müller, M C, Wolf, D

Volltext

Fibroblast growth factor-2 promotes in vitro activation of cat primordial follicles von Müller, M.C., Monte, A.P.O., Lins, T.L.B.G., Macedo, T.J.S., Barros, V.R.P., Ferreira, V.C., Baraúna, D., Santos, C.R.O., Silva, A.R., Matos, M.H.T.

Volltext

Effects of melatonin on the in vitro growth of early antral follicles and maturation of ovine oocytes von Barros, V.R.P., Monte, A.P.O., Santos, J.M.S., Lins, T.L.B.G., Cavalcante, A.Y.P., Gouveia, B.B., Müller, M.C., Oliveira Junior, J.L., Barberino, R.S., Donfack, N.J., Araújo, V.R., Matos, M.H.T.

Volltext

Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories von Müller, M C, Erben, P, Saglio, G, Gottardi, E, Nyvold, C G, Schenk, T, Ernst, T, Lauber, S, Kruth, J, Hehlmann, R, Hochhaus, A

Volltext

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders... von Rohrbacher, M, Berger, U, Hochhaus, A, Metzgeroth, G, Adam, K, Lahaye, T, Saussele, S, Müller, M C, Hasford, J, Heimpel, H, Hehlmann, R

Volltext